Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPA and HMG controlled ovarian stimulation in women with polycystic ovarian syndrome
ChiCTR-OCH-14004424Phase 4Completed
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of medroxyprogesterone acetate and human menopausal gonadotrophin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Number of oocytes retrieved. Started Jan 2014; status: completed.
02
Drugs
medroxyprogesterone acetatehuman menopausal gonadotrophin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-OCH-14004424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14004424.